Consequently, Choi et al. assessed the expression levels of 22 proteins from pre-treatment biopsies of 181 locally advanced cervical cancer specimens and identified a panel of BCL2, HER2, CD133, CA9 and ERCC1 as an independent predictor of survival after CRT [157]. This evidence concerns the gene CA9 and cervical cancer.